Cigarette Smoking and Psychiatric Illness Among Individuals with COPD: a Systematic Review

J Levin, D Estey, E Yadgaran, E Perez, I Plotnick… - Current Addiction …, 2024 - Springer
Abstract Purpose of Review Both smoking and psychiatric illness are independently
associated with poorer COPD-related health outcomes, but little is known about the course …

A qualitative study on people with opioid use disorders' perspectives on smoking and smoking cessation interventions

KT Druckrey-Fiskaaen, E Furulund, T Madebo… - Frontiers in …, 2023 - frontiersin.org
Introduction Smoking-related diseases are major contributors to disability and shorter life
expectancy among opioid-dependent patients. Smoking prevalence is considerably higher …

[HTML][HTML] Burden and treatment of chronic obstructive pulmonary disease among people using illicit opioids: matched cohort study in England

D Lewer, S Cox, JR Hurst, P Padmanathan… - BMJ …, 2022 - ncbi.nlm.nih.gov
Burden and treatment of chronic obstructive pulmonary disease among people using illicit
opioids: matched cohort study in England - PMC Back to Top Skip to main content NIH NLM …

Blockade of 5-hydroxytryptamine 2A receptor attenuates precipitation of naloxone-induced withdrawal symptoms in opioid-exposed mice

B Li, J Jiang, L Zhou, X Tao, Q Sun, J Liu… - Frontiers in Behavioral …, 2022 - frontiersin.org
Heroin dependency has become a global problem and has caused significant clinical and
socioeconomic burdens along with devastating medical consequences. Chronic drug …

Organ pathologies detected post‐mortem in patients receiving opioid agonist treatment for opioid use disorder: a nation‐wide 2‐year cross‐sectional study

AB Bech, T Clausen, H Waal, GJM Delaveris… - Addiction, 2022 - Wiley Online Library
Aims To document organ pathologies detected post‐mortem in patients receiving opioid
agonist treatment for opioid use disorder and estimate the extent to which individual …

High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study

P Bruggmann, O Senn, A Frei, MA Puhan, J Fehr… - Swiss Medical …, 2022 - smw.ch
BACKGROUND AND AIMS: Among people on opioid agonist treatment (OAT), social-
environmental and behavioural risk factors may promote the spread of SARS-CoV-2, and …

[HTML][HTML] The association between dual use of electronic nicotine products and illicit drugs with adverse cardiovascular and respiratory outcomes in a longitudinal …

F Qeadan, A Nicolson, WA Barbeau, S Azagba… - Drug and alcohol …, 2023 - Elsevier
Background Drug use and electronic nicotine delivery systems (ENDS) are independently
associated with increased risk of cardiovascular and respiratory outcomes. Literature on the …

Pathologies bronchiques et usage d'héroïne. Revue systématique

M Underner, J Perriot, G Peiffer, G Brousse… - Revue des Maladies …, 2023 - Elsevier
Résumé Introduction L'usage d'héroïne peut causer des complications respiratoires dont
l'asthme, la bronchopneumopathie chronique obstructive (BPCO) et les bronchectasies …

Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease

X Tang, C Xu, T Zhou, Y Qiang, Y Wu - Open Life Sciences, 2024 - degruyter.com
The objective of this study was to investigate the relationship between low attenuation area
(LAA) scores, pulmonary function parameters, and clinical prognosis in patients with chronic …

Management of dependent use of illicit opioids

C Mitchell, N Dolan, KM Dürsteler - Bmj, 2020 - bmj.com
Use of illicit opioids, most commonly heroin, has a wide ranging impact on individuals and
society. 1 It may lead to dependence, which is best conceptualised using a “chronic disease” …